Skip to main content
. Author manuscript; available in PMC: 2010 Mar 3.
Published in final edited form as: Circulation. 2009 Feb 16;119(8):1101–1107. doi: 10.1161/CIRCULATIONAHA.108.821769

Table 1. Baseline Characteristics of Study Participants.

Characteristic Men
(N=235)
Women
(N=360)
Clinical Data
Age, yrs 54±9 55±9
Body mass index, kg/m2 27.1±3.8 25.5±4.9
Systolic blood pressure, mm Hg 119±10 115±13
Diastolic blood pressure, mm Hg 75±7 70±8
 Optimal BP, % 48.9 59.7
 Normal BP % 27.7 21.7
Diabetes, % 5.5 2.2
Current cigarette smoking, % 14.0 18.1
Weight change, % 0.7±5.3 1.1±6.5
Sex-specific LVID and LVWT distributions, %
 LVID and LVWT <50th percentile 73.6 72.2
 LVID or LVWT >90th percentile 26.4 27.8
Matrix remodeling markers, ng/mL
TIMP-1, median IQR 776 (154) 734 (148)
PIIINP, median IQR 3.08 (1.47) 3.03 (1.55)
MMP-9, % detectable 17.5 17.3

All values are mean ± standard deviation or otherwise indicated

Optimal blood pressure, systolic <120 mm Hg and diastolic <80 mm Hg; normal blood pressure, systolic 120-129 mm Hg or diastolic 80-84 mm Hg; high normal blood pressure, systolic 130-139 mm Hg or diastolic 85-89 mm Hg.

TIMP-1: tissue inhibitor of metalloprotein-1; MMP-9: matrix metalloprotein-9; PIIINP: procollagen III N terminal peptide; LVID: Left ventricular internal dimension; LVWT: left ventricular wall thickness